BioSpace News Archive

Fractyl Health to Present Preclinical Proof-of-Concept Data for Rejuva ® Pancreatic Gene Therapy Platform Program at the American Society of Gene & Cell Therapy Congress.

Boehringer Ingelheim announced today that it has launched clinical development of its first-in-class IL-11 inhibitor antibody BI 765423 with a Phase 1 study ( NCT05658107 ) to assess the safety, tolerability, and pharmacokinetics in healthy volunteers.

ZyVersa Therapeutics, Inc. announces that Stephen C. Glover, Co-Founder, Chairman, Chief Executive Officer, and President, will participate in the 2023 BIO International Convention being held June 5 - 8, 2023 in Boston, Massachusetts.

Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial results for the first quarter ended March 31, 2023.

Outpace Bio, a company using protein design and cell engineering to create advanced cell therapies with curative potential, announced that an abstract was selected for poster presentation at the upcoming American Society of Gene & Cell Therapy 26th Annual meeting being held from May 16-20, 2023 in Los Angeles, CA.

Amgen (NASDAQ:AMGN) and TScan Therapeutics, Inc. (NASDAQ:TCRX), today announced a multi-year collaboration that will use TScan’s proprietary target discovery platform, TargetScan, to identify the antigens recognized by T cells in patients with Crohn’s disease.

G-Tech Medical, a developer of non-invasive diagnostic solutions for patients with gastrointestinal disorders, today announced presentation of a poster at the Digestive Disease Week Annual Meeting held in Chicago May 6-9.

Alpha Pro Tech, Ltd., a leading manufacturer of products designed to protect people, products and environments, including disposable protective apparel and building products, announced financial results for the three month period ended March 31, 2023.

HALO Precision Diagnostics, the leader in early disease detection using precision diagnostics, announced its partnership with Agamon Health, the leader in Generative AI/NLP-powered automated solutions for patient workflow management.

Centinel Spine®, LLC, a leading global medical device company addressing cervical and lumbar spinal disease by providing the most robust and clinically-proven total disc replacement technology platform in the world, will present at the 2023 Castellvi Spine Symposium, being held May 10-13 in Duck Key, Florida.